31 results on '"Rizzieri, David"'
Search Results
2. HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group
3. A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy
4. Cyclophosphamide-Based Hematopoietic Stem Cell Mobilization Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
5. Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/μl
6. Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment
7. Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002
8. Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement
9. New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation
10. Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia
11. Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL)
12. A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
13. Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia
14. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
15. Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B
16. Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia
17. Phase II Multicenter Study of Arsenic Trioxide in Patients With Myelodysplastic Syndromes
18. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
19. Dose-Intense Cyclophosphamide and Etoposide for Patients with Refractory or High-Risk Non-Hodgkinʼs Lymphoma
20. Pulmonary Sarcoidosis Following Stem Cell Transplantation*: Is It More Than a Chance Occurrence?
21. An EBV-Positive Lymphoproliferative Disorder after Therapy with Alemtuzumab
22. Rituximab in Lymphocyte Predominance Hodgkinʼs Disease: A Case Series
23. Phase I Evaluation of Prolonged-Infusion Gemcitabine With Irinotecan for Relapsed or Refractory Leukemia or Lymphoma
24. Phase I Evaluation of Prolonged-Infusion Gemcitabine With Mitoxantrone for Relapsed or Refractory Acute Leukemia
25. Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma
26. Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
27. Thrombocytosis Associated with Low-Molecular-Weight Heparin
28. Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor
29. Thrombocytosis Associated with Low-Molecular-Weight Heparin
30. In response: Causes of Rhabdomyolysis
31. Rhabdomyolysis After Correction of Hyponatremia Due to Psychogenic Polydipsia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.